Skip to content
Disclosery

GENERAL ATLANTIC, L.P.

Follow

13F filer, CIK 1017645, New York, NY

GENERAL ATLANTIC, L.P. reported $2,872,723,178 across 13 holdings for the quarter ended 2025-12-31, in a 13F-HR filed 2026-02-17. Its ten largest share positions make up 98.97% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950142-26-000395

Period
2025-12-31
Reported value
$2.87B
Holdings
13
Top 10 weight
98.97%
New
1
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NRIXnew+4,897,159$92.9M
CHYMadded+2,050,923$51.6M
RVMDadded+338,500$27M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
AKROexited-5,733,989-$272M
ALHCreduced-11,119,494-$220M
CNTAreduced-3,564,103-$89.1M
BULLreduced-7,148,051-$55.5M
RPRXexited-1,500,000-$52.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2025

Share positions as resolved from 13F-HR 0000950142-26-000395, largest first. % of portfolio is the value over $2,872,723,178, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
DLODLOCAL LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 63,906,695 shares; 2024Q4: 63,906,695 shares; 2025Q1: 63,906,695 shares; 2025Q2: 63,906,695 shares; 2025Q3: 46,656,695 shares; 2025Q4: 46,656,695 shares 46,656,695$660M22.97%0Timeline
CHYMCHIME FINL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 19,208,760 shares; 2025Q3: 19,208,760 shares; 2025Q4: 21,259,683 shares 21,259,683$535M18.63%+2,050,923Timeline
XPXP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 29,617,733 shares; 2024Q4: 29,617,733 shares; 2025Q1: 29,617,733 shares; 2025Q2: 25,517,733 shares; 2025Q3: 25,517,733 shares; 2025Q4: 22,699,133 shares 22,699,133$372M12.93%-2,818,600Timeline
ALKTALKAMI TECHNOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 15,520,318 shares; 2024Q4: 9,645,318 shares; 2025Q1: 9,645,318 shares; 2025Q2: 9,645,318 shares; 2025Q3: 11,991,480 shares; 2025Q4: 11,991,480 shares 11,991,480$277M9.63%0Timeline
ALHCALIGNMENT HEALTHCARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,993,323 shares; 2024Q4: 60,993,323 shares; 2025Q1: 60,993,323 shares; 2025Q2: 43,993,323 shares; 2025Q3: 24,287,227 shares; 2025Q4: 13,167,733 shares 13,167,733$260M9.05%-11,119,494Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,474,428 shares; 2025Q4: 2,812,928 shares 2,812,928$224M7.8%+338,500Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,531,252 shares; 2024Q4: 7,531,252 shares; 2025Q1: 7,531,252 shares; 2025Q2: 7,531,252 shares; 2025Q3: 8,031,252 shares; 2025Q4: 8,031,252 shares 8,031,252$223M7.76%0Timeline
CNTACENTESSA PHARMACEUTICALS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,681,818 shares; 2024Q4: 9,681,818 shares; 2025Q1: 9,681,818 shares; 2025Q2: 9,681,818 shares; 2025Q3: 9,681,818 shares; 2025Q4: 6,117,715 shares 6,117,715$153M5.33%-3,564,103Timeline
NRIXNURIX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,897,159 shares 4,897,159$92.9M3.23%newTimeline
EWCZEUROPEAN WAX CTR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 13,110,492 shares; 2024Q4: 13,110,492 shares; 2025Q1: 13,110,492 shares; 2025Q2: 13,110,492 shares; 2025Q3: 13,110,492 shares; 2025Q4: 13,110,492 shares 13,110,492$47.2M1.64%0Timeline
RSKDRISKIFIED LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,324,998 shares; 2024Q4: 5,324,998 shares; 2025Q1: 5,324,998 shares; 2025Q2: 5,324,998 shares; 2025Q3: 5,324,998 shares; 2025Q4: 5,324,998 shares 5,324,998$26.5M0.92%0Timeline
GROVGROVE COLLABORATIVE HOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 936,020 shares; 2024Q4: 2,474,859 shares; 2025Q1: 2,474,859 shares; 2025Q2: 2,474,859 shares; 2025Q3: 2,474,859 shares; 2025Q4: 2,474,859 shares 2,474,859$2.72M0.09%0Timeline
BULLWEBULL CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 7,148,051 shares; 2025Q3: 7,198,867 shares; 2025Q4: 50,816 shares 50,816$395K0.01%-7,148,051Timeline

Sold out in Q4 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
AKROAKERO THERAPEUTICS INC5,733,989$272Mshares
RPRXROYALTY PHARMA PLC1,500,000$52.9Mshares
ADAGADAGENE INC3,782,339$7.53Mshares
ALMSALUMIS INC1,297,530$5.18Mshares

How Q4 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950142-26-000395 base2026-02-17acceptance time not in the bulk data set